Skip to main content
Menu
search

Distributed and Point-of-Care Manufacturing – Building Infrastructure and Capacity

Distributed and Point-of-Care Manufacturing – Building Infrastructure and Capacity

Industry:
Biopharma

Type:
Podcast

Location:
Miami, Florida

The promise of cell and gene therapies will be realized when patient access becomes more commonplace. In studies, 9 out of 10 people with acute lymphoblastic leukemia whose cancer didn't respond to other treatments or whose cancer came back had full remission with CAR T-cell therapy. How do we prepare for a future where CAR-T is a first line therapy for indications that affect broad patient groups? Watch the discussion on Distributed and Point-of-Care Manufacturing – Building Infrastructure and Capacity below with Carol Houts, Edwin Stone, and Krisha Patel.

You might also be interested in

Video

Inside the Innovation: Mobile CL-2 Laboratory Walkthrough

Discover how our team's design and engineering efforts have created a versatile solution for various processes and applications.
Articles

Optimizing Pharmaceutical Isolator Design

This article delves into the world of isolators, exploring their importance in the pharmaceutical and biotech industries, the challenges of innovating aseptic isolator design, best practices, key aspects of design…
Constructing Capabilities: Holistic Infrastructure Development in Decentralized Manufacturing
Video

Constructing Capabilities: Holistic Infrastructure Development in Decentralized Manufacturing

Dive into this discussion around decentralized manufacturing and the importance of designing identical and cloned processes, focusing on a copy-paste model for multiple locations.

Contact us: Let's unlock your scientific potential together

Complete our contact form and a member of our commercial team will contact you within 24 hours.

White email icon on a green diamond

Service & support: cs@germfree.com